Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-09

Clinical Trial Results: Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety of autologous stem cell infusion in children with sensorineural hearing loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: James Baumgartner, MD | Conditions: Sensorineural Hearing Loss | Phase 1 | Status: COMPLETED | Results posted: 2026-07-09